3581 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 72 | next »
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
Prognostic p-valuei x
RNA cancer categoryi x
RNA tissue categoryi x
A1BGAlpha-1-B glycoproteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 3.97e-4
Tissue enrichedTissue enriched
A1CFAPOBEC1 complementation factorPredicted intracellular proteins
NucleoplasmTissue enrichedTissue enhanced
A4GNTAlpha-1,4-N-acetylglucosaminyltransferasePredicted secreted proteins
Group enrichedTissue enriched
AARDAlanine and arginine rich domain containing proteinPredicted intracellular proteins
Lipid dropletsTissue enrichedTissue enriched
AATKApoptosis associated tyrosine kinaseEnzymes
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaMixedTissue enhanced
ABCA10ATP binding cassette subfamily A member 10Predicted intracellular proteins
Predicted membrane proteins
Transporters
MixedMixed
ABCA6ATP binding cassette subfamily A member 6Predicted intracellular proteins
Predicted membrane proteins
Transporters
NucleoplasmLiver cancer: 3.29e-4
Tissue enrichedTissue enhanced
ABCA8ATP binding cassette subfamily A member 8Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
MixedMixed
ABCA9ATP binding cassette subfamily A member 9Predicted membrane proteins
Transporters
Endoplasmic reticulumMixedMixed
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedTissue enhanced
ABCB11ATP binding cassette subfamily B member 11Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Tissue enrichedTissue enriched
ABCB4ATP binding cassette subfamily B member 4Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Actin filaments
Focal adhesion sites
Tissue enrichedTissue enriched
ABCB5ATP binding cassette subfamily B member 5Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enrichedTissue enriched
ABCC11ATP binding cassette subfamily C member 11Predicted intracellular proteins
Predicted membrane proteins
Group enrichedTissue enriched
ABCC12ATP binding cassette subfamily C member 12Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhancedTissue enhanced
ABCC2ATP binding cassette subfamily C member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 1.93e-5
Tissue enhancedGroup enriched
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedTissue enhanced
ABCC8ATP binding cassette subfamily C member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoli
Golgi apparatus
Cytosol
Tissue enrichedTissue enhanced
ABCD2ATP binding cassette subfamily D member 2Predicted membrane proteins
Transporters
Tissue enrichedTissue enhanced
ABCG5ATP binding cassette subfamily G member 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleusLiver cancer: 2.60e-5
Tissue enrichedGroup enriched
ABCG8ATP binding cassette subfamily G member 8Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesTissue enrichedGroup enriched
ABHD1Abhydrolase domain containing 1Predicted membrane proteins
Predicted secreted proteins
MixedTissue enriched
ABHD12BAbhydrolase domain containing 12BPredicted intracellular proteins
NucleusTissue enrichedTissue enriched
AC002429.5Predicted intracellular proteins
Tissue enrichedTissue enriched
AC009014.3Predicted membrane proteins
Liver cancer: 1.63e-4
Pancreatic cancer: 6.13e-4
Tissue enhancedTissue enhanced
AC011513.3Predicted secreted proteins
Tissue enhancedGroup enriched
AC092835.2Predicted intracellular proteins
MixedMixed
ACAD11Acyl-CoA dehydrogenase family member 11Predicted intracellular proteins
Tissue enhancedExpressed in all
ACADLAcyl-CoA dehydrogenase, long chainDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 1.58e-11
Group enrichedTissue enhanced
ACANAggrecanPredicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.47e-6
MixedTissue enhanced
ACBD7Acyl-CoA binding domain containing 7Predicted intracellular proteins
Vesicles
Cytosol
MixedTissue enriched
ACCSL1-aminocyclopropane-1-carboxylate synthase homolog (inactive) likePredicted intracellular proteins
Tissue enrichedNot detected
ACMSDAminocarboxymuconate semialdehyde decarboxylaseEnzymes
Predicted intracellular proteins
Renal cancer: 2.39e-4
Group enrichedGroup enriched
ACOT12Acyl-CoA thioesterase 12Enzymes
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Liver cancer: 5.30e-4
Tissue enrichedTissue enriched
ACOX2Acyl-CoA oxidase 2Enzymes
Predicted intracellular proteins
Vesicles
Cytosol
Tissue enhancedTissue enhanced
ACOXLAcyl-CoA oxidase-likePredicted intracellular proteins
Nucleoli
Cytosol
Urothelial cancer: 6.48e-4
Group enrichedGroup enriched
ACPTAcid phosphatase, testicularDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
MixedTissue enhanced
ACRBPAcrosin binding proteinPredicted secreted proteins
Nucleoplasm
Vesicles
MixedTissue enriched
ACRV1Acrosomal vesicle protein 1Predicted secreted proteins
MixedTissue enriched
ACSBG1Acyl-CoA synthetase bubblegum family member 1Enzymes
Predicted intracellular proteins
VesiclesTissue enhancedTissue enhanced
ACSL6Acyl-CoA synthetase long-chain family member 6Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedGroup enriched
ACSM1Acyl-CoA synthetase medium-chain family member 1Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedTissue enriched
ACSM2AAcyl-CoA synthetase medium-chain family member 2AEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 1.41e-5
Group enrichedGroup enriched
ACSM2BAcyl-CoA synthetase medium-chain family member 2BEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 3.31e-4
Group enrichedGroup enriched
ACSM3Acyl-CoA synthetase medium-chain family member 3Enzymes
Predicted intracellular proteins
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
MixedTissue enhanced
ACSM5Acyl-CoA synthetase medium-chain family member 5Enzymes
Predicted intracellular proteins
Group enrichedTissue enriched
ACSM6Acyl-CoA synthetase medium-chain family member 6Enzymes
Predicted membrane proteins
Urothelial cancer: 7.71e-4
Tissue enrichedTissue enhanced
ACSS3Acyl-CoA synthetase short-chain family member 3Enzymes
Predicted membrane proteins
MitochondriaRenal cancer: 0.00e+0
MixedMixed
ACTL6BActin like 6BPredicted intracellular proteins
NucleoliGroup enrichedTissue enriched
ACTN3Actinin alpha 3 (gene/pseudogene)Plasma proteins
Predicted intracellular proteins
Tissue enhancedTissue enriched
Page of 72 | next »